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Abstract  
Background: Dietary carbohydrate, glycemic load and glycemic index are thought to 
influence colorectal cancer risk through hyperinsulinemia. We review and quantitatively 
summarize in a meta-analysis the evidence from prospective cohort studies.  
 
Methods: We searched the PubMed database for prospective studies of carbohydrate, 
glycemix index and glycemic load and colorectal cancer risk, up to December 2010. 
Summary relative risks were estimated by use of a random effects model.  
 
Results: We identified 14 cohort studies that could be included in the meta-analysis of 
carbohydrate, glycemic index and glycemic load and colorectal cancer risk. The summary RR 
high vs. low intake was 1.00 (95% CI: 0.87-1.14 I
2
=31%) for carbohydrate, 1.07 (95% CI: 
0.99-1.16, I
2
=28%) for glycemic index, and 1.00 (95% CI: 0.91-1.10, I
2
=39%) for glycemic 
load. In the dose-response analysis the summary RR was 0.97 (95% CI: 0.87-1.09, I
2
=51%) 
per 100 grams of carbohydrate per day, 1.07 (95% CI: 0.99-1.15, I
2
=39%) per 10 glycemic 
index units and 1.00 (95% CI: 0.94-1.06, I
2
=50%) per 50 glycemic load units. Exclusion of 
one outlier study reduced the heterogeneity, but the results were similar.  
 
Conclusion: This meta-analysis of cohort studies does not support an independent 
association between diets high in carbohydrate, glycemic index or glycemic load.  
 
Word count abstract: 199 
Key words: Carbohydrate, glycemic index, glycemic load, colorectal cancer, meta-analysis 
Conflict of interest: None declared.  
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Colorectal cancer is the third most common cancer worldwide with approximately 1.23 
million new cases diagnosed in 2008 accounting for one in ten incident cancers (1). 
Ecological studies, secular trend studies and migration studies have shown that environmental 
factors including lifestyle are likely to be important determinants of colorectal cancer risk (2-
4). However, although dietary factors are known to be important in colorectal cancer 
etiology, only intake of alcohol and red and processed meat are considered to be convincingly 
associated with colorectal cancer (5). 
Several lines of evidence indicate that insulin resistance may play a role in the 
etiology of colorectal cancer. Some risk factors for colorectal cancer including overweight 
and obesity, low physical activity and type 2 diabetes are linked to insulin resistance (5-7). 
Epidemiological studies have reported increased colorectal cancer risk with elevated blood 
glucose or C-peptide (8-14). Dietary carbohydrate is the main dietary component affecting an 
individual’s insulin secretion and glycemic response (15). Glycemic index (GI) is an index 
for ranking foods according to their effect on blood glucose concentrations and is defined as 
the area under the two hour blood glucose response curve (AUC) following intake of 50 
grams carbohydrate from a particular food (16). The AUC for the test food is divided by the 
AUC of a reference, which is glucose or white bread, and multiplied by 100. The GI applies 
to foods with a reasonable carbohydrate content. Because some foods contain very little 
carbohydrate one would have to eat large amounts of the food to yield 50 gram carbohydrate. 
Glycemic load (GL) is a ranking system for the carbohydrate content of food which takes into 
account the portion size (GL= (GI x amount of available carbohydrate)/100) (17).  
Several studies have investigated the association between diets high in carbohydrate, 
glycemic index or glycemic load and colorectal cancer risk, however, the results have been 
inconsistent (18-31). A previous meta-analysis found an elevated colorectal cancer risk with a 
high GI and GL among case-control studies, but not among cohort studies (32). Three large 
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additional cohort studies have since been published on the subject (29-31) and here we update 
the evidence published up to December 2010. In addition, because to our knowledge a meta-
analysis of carbohydrate intake and colorectal cancer has not been published we expanded the 
meta-analysis to include total carbohydrate and specific types of carbohydrate (excluding 
fiber). 
 
Methods  
Search strategy 
The Pubmed database was searched up to December 2010 for studies of carbohydrate intake, 
glycemic index or glycemic load and colorectal cancer risk. We followed a predefined 
protocol for the review (http://www.dietandcancerreport.org/downloads/SLR_Manual.pdf) 
which includes details of the search terms and standard criteria for meta-analyses of 
observational studies (33). We also searched the reference lists of all the studies that were 
included in our analysis as well as those listed in the published systematic reviews and meta-
analyses (32,34).  
 
Study selection 
We included prospective cohort studies, case-cohort studies and nested case-control studies 
which investigated the association between dietary carbohydrate, GI or GL and colorectal 
cancer risk. Estimates of the relative risk (hazard ratio, risk ratio) had to be available with the 
95% confidence intervals in the publication and for the dose-response analysis, a quantitative 
measure of intake had to be provided. We identified 18 possibly relevant publications in the 
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search (18-31,35-38) (Figure 1). Four of these were excluded because no risk estimates were 
presented (35-38). Three  publications were excluded from the dose-response analysis 
because they presented carbohydrate intake as a percentage of total energy intake, not in 
grams per day (19,26) or did not quantify carbohydrate intake (20). 
 
Data extraction 
The following data were extracted from each study: The first author’s last name, publication 
year, country where the study was conducted, the study name, follow-up period, sample size, 
gender, age, number of cases, dietary assessment method (type, number of food items and 
whether it had been validated), exposure, quantity of intake, RRs and 95% CIs and variables 
adjusted for in the analysis. Data were extracted into a database by one author (D. A.) and 
was checked for accuracy by two authors (T. N and D. A.).  
 
Statistical methods 
Random effects models were used to calculate summary RRs and 95% CIs for the highest vs. 
the lowest level of carbohydrate, GI, and GL intake and for the dose-response analysis (39). 
The average of the natural logarithm of the RRs was estimated and the RR from each study 
was weighted by the inverse of its variance. A two-tailed p<0.05 was considered statistically 
significant. For studies that reported results separately for men and women or proximal and 
distal colon, but not combined, we pooled the results using a fixed-effects model to obtain an 
overall combined estimate before combining with the rest of the studies.  
 The method described by Greenland and Longnecker (40) was used for the dose–
response analysis and we computed study-specific slopes (linear trends) and 95% CIs from 
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the natural logs of the RRs and CIs across categories of carbohydrate and GI/GL intake. The 
method requires that the distribution of cases and person-years or non-cases and the RRs with 
the variance estimates for at least three quantitative exposure categories are known. The 
distribution of cases or person-years were estimated in studies that did not report these, but 
reported the total number of cases/person-years, if the results were analyzed by quantiles (and 
could be approximated). For example, the total number of person-years was divided by 5 
when data were analyzed by quintiles in order to derive the number of person-years in each 
quintile. The median or mean level of intake in each category of intake was assigned to the 
corresponding relative risk for each study. For studies that reported intakes by ranges we 
estimated the midpoint in each category by calculating the average of the lower and upper 
bound. When the highest or lowest category was open-ended we assumed the open-ended 
interval length to be the same as the adjacent interval. If the intakes were reported in densities 
(i.e. gram per 1000 kcal) we recalculated the reported intakes to absolute intakes using the 
mean or median energy intake. The dose-response results in the forest plots are presented for 
a 10 and 50 unit increment per day for glycemic index and glycemic load, respectively and 
for a 100 gram per day increment for carbohydrate.  
 Heterogeneity between studies was assessed by the Q test and I
2
 (41), the amount of 
total variation that is explained by between study variation. Subgroup and meta-regression 
analyses by sex, duration of follow-up, number of cases, geographic location and adjustment 
for confounding factors such as body mass index, smoking, alcohol, physical activity, intake 
of fruit and vegetables, energy and red and processed meat were conducted to investigate 
potential sources of heterogeneity. Publication bias was assessed with Egger’s test (42) and 
with Begg’s test (43) and the results were considered to indicate publication bias when 
p<0.10. We conducted sensitivity analyses excluding one study at a time to investigate 
whether the results were due to one large study or a study with an extreme result.  
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Results 
We identified 14 cohort studies (18-31) that were included in the analysis of the highest vs. 
the lowest carbohydrate, GI and GL intake and colorectal cancer risk and 11 of these studies 
(21-31) were included in the dose-response analysis (Table 1, Figure 1). Eleven studies were 
from North-America, two from Europe and one from Asia.  
 
Glycemic index 
High vs. low analysis 
Ten cohort studies (nine publications) (22-28,30,31) investigated the association between 
glycemic index and colorectal cancer risk and included 12382 cases among 994154 
participants. The summary RR for all studies was 1.07 (95% CI: 0.99-1.16), with no 
significant heterogeneity, I
2
=28% and pheterogeneity=0.19 (Figure 2a).  
 
Dose-response analysis 
Ten cohort studies (nine publications) (22-28,30,31) were included in the dose-response 
analysis of glycemic index and colorectal cancer risk. The summary RR per 10 units per day 
was 1.07 (95% CI: 0.99-1.15), with little evidence of heterogeneity, I
2
=39% and 
pheterogeneity=0.10 (Figure 2b). The summary RR for colorectal cancer ranged from 1.04 (95% 
CI: 0.97-1.13) when the NIH-AARP Diet and Health Study (30) was excluded to 1.11 (95% 
CI: 1.05-1.17) when the Breast Cancer Detection Demonstration Project (26) was excluded. 
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There was no indication of publication bias with Egger’s test, p=0.34 or with Begg’s test, 
p=0.28.  
 
Glycemic load 
High vs. low analysis 
Twelve cohort studies (eleven publications) (21-31) were included in the analysis of high 
versus glycemic load and colorectal cancer risk and included a total of 15377 cases among 
1234282 participants. The summary RR was 1.00 (95% CI: 0.91-1.10), with moderate 
heterogeneity, I
2
=39%, pheterogeneity=0.08 (Figure 3a).  
 
Dose-response analysis 
Twelve cohort studies (eleven publications) (21-31) were included in the dose-response 
analysis. The summary RR per 50 units per day was 1.00 (95% CI: 0.94-1.06), with moderate 
heterogeneity, I
2
=50%, pheterogeneity=0.03 (Figure 3b). In a sensitivity analysis the summary 
RR for colorectal cancer ranged from 0.98 (95% CI: 0.92-1.03) when excluding the Health 
Professionals Follow-up Study (23) to 1.01 (95% CI: 0.94-1.09) when excluding the NIH-
AARP Diet and Health Study (30). There was no indication of publication bias with Egger’s 
test, p=0.12 or with Begg’s test, p=0.37. The heterogeneity was largely explained by the 
results from the Women’s Health Study (22), which seemed to be an outlier, and when 
excluded the results were similar, summary RR=0.99 (95% CI: 0.94-1.04), but the 
heterogeneity was reduced, I
2
=32%, pheterogeneity=0.15.  
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Carbohydrate  
High vs. low analysis 
Twelve cohort studies (11 publications) examined (19-26,28,29,31) total carbohydrate intake 
and colorectal cancer risk and included 9799 cases among 806647 participants. The summary 
RR was 0.93 (95% CI: 0.84-1.04) with moderate heterogeneity, I
2
=40%, pheterogeneity=0.08 
(Figure 4a).  
 
Dose-response analysis 
Ten cohort studies (9 publications) (21-26,28,29,31) were included in the dose-response 
analysis. The summary RR per 100 g/d was 0.95 (95% CI: 0.84-1.07), with moderate 
heterogeneity, I
2
=58%, pheterogeneity=0.01 (Figure 4b). The summary RR ranged from 0.92 
(95% CI: 0.82-1.03) when excluding the Health Professionals Follow-up Study (23) to 0.98 
(95% CI: 0.87-1.09) when excluding the Breast Cancer Detection Demonstration Project 
(26). There was no evidence of publication bias with Egger’s test, p=0.42 or with Begg’s test, 
p=0.37.  
 
Specific types of carbohydrate 
Only four (three publications) (22-24) and five studies (four publications) (22-24,29) were 
included in the analyses of high versus low sucrose and fructose intake and colorectal cancer, 
respectively. The summary RR was 1.11 (95% CI: 0.82-1.50, I
2
=79%, pheterogeneity=0.002) for 
sucrose intake (Figure 5a) and 0.99 (95% CI: 0.82-1.20, I
2
=63%, pheterogeneity=0.03) for 
fructose intake (Figure 5b).  
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Subgroup, meta-regression analyses and sensitivity analyses 
In meta-regression analyses only adjustment for physical activity was a significant predictor 
of heterogeneity in the analysis of glycemic index, pheterogeneity=0.03. A significant positive 
association was found among studies that adjusted for physical activity. In addition, a 
significant positive association between glycemic index and colorectal cancer was observed 
among men, but there was no evidence of heterogeneity between genders. There were no 
significant predictors of heterogeneity in subgroup analyses of glycemic load or 
carbohydrate, although for carbohydrate, there was borderline evidence of a positive 
association among men, but not among women, pheterogeneity=0.07.  
 In a sensitivity analysis we included one study in the dose-response analysis that 
reported carbohydrate intake as a percentage of energy intake, by recalculating the intake to 
grams using the mean energy intake among noncases (19). The summary RR was 0.94 (95% 
CI: 0.85-1.05, I
2
=55%, pheterogeneity=0.02).  
 
Discussion 
We found no statistically significant association between dietary carbohydrate, 
glycemic index or glycemic load and colorectal cancer risk in categorical and dose-response 
meta-analyses. In the analysis of carbohydrate and glycemic load and colorectal cancer there 
was significant heterogeneity, however, this was largely explained by one outlying study.   
Although case-control studies have provided some evidence of a positive association 
(32,34), these studies may be prone to selection and recall biases which can make it difficult 
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to draw firm conclusions. Our results, which are based on prospective studies are not prone to 
recall bias, because diet is assessed before the development of disease, and in addition, 
selection bias is less likely to have influenced these results.  
 Our meta-analysis may have several limitations which must be taken into 
consideration. Intake of diets high in carbohydrate, GI and GL may be associated with other 
behaviors including physical activity, overweight and obesity, smoking and intake of alcohol 
and red and processed meat. The association between intake of carbohydrate, GI and GL and 
the confounding factors may differ between studies and populations (22,25,30,31), but 
nevertheless, we generally did not find evidence of significant heterogeneity between 
subgroups in our analyses. In stratified analyses and meta-regression analyses only one 
subgroup analysis showed significant heterogeneity between studies that adjusted or did not 
adjust for confounders. There was a significant positive association between glycemic index 
and colorectal cancer in studies that adjusted for physical activity, but a non-significant 
inverse association among studies that did not adjust for physical activity. Due to the 
numerous comparisons this finding may have been a chance finding. We found no statistical 
evidence of publication bias in this analysis, but we may have had limited power to detect 
such bias due to the limited number of studies.  
 Measurement errors in the assessment of dietary intake are known to bias effect 
estimates, however, none of the studies included in this meta-analysis made any corrections 
for measurement errors. Assessment of GI or GL may in this respect be particularly 
challenging, because these measures are based on their postprandial blood glucose response 
and are not concentration values of nutrients in the foods consumed. Most dietary 
questionnaires have estimated usual GI/GL values based on a limited number of food items, 
which may not have been specifically selected and validated for dietary GI or GL. However, 
when we evaluated total carbohydrate intake we found similar to the analyses of GI and GL 
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no significant association. In addition, the studies that have evaluated the association between 
glycemic index, glycemic load or carbohydrate intakes and colorectal adenomas found no 
evidence of an increased risk (44-51), and some even a suggestive inverse association (44,48-
51). Studies using similar questionnaires have been able to detect associations between GI, 
GL and risk of type 2 diabetes (52) and cardiovascular disease (53), but nevertheless we 
cannot exclude the possibility that a more modest or weak association with colorectal cancer 
may have been missed due to measurement errors.  
 Our meta-analysis also has several strengths. Because we based our analyses on 
prospective studies we have effectively avoided recall and selection bias. The studies 
included a larger number of cases and participants than any previous meta-analysis on the 
topic that we are aware of, with a total of approximately 0.8-1.2 million participants and 
≈8900-15000 cases. Thus, we had statistical power to detect moderate associations. Although 
we cannot exclude the possibility that a very weak association with a high GI may have been 
obscured due to measurement errors, our study, with an even larger sample size than 
available previously, does not provide support for the hypothesis that intake of diets high in 
carbohydrate, GI or GL is strongly associated with colorectal cancer risk.  
 In conclusion, our results do not support the hypothesis that dietary carbohydrate, GI 
or GL are associated with colorectal cancer risk.  
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Table 1: Prospective cohort studies of intake of carbohydrate, glycemic index and glycemic load and colorectal cancer risk 
 
Author, 
publication 
year, country 
Study name Follow-up 
period 
Study size, 
gender, age, 
number of cases 
Dietary 
assessment  
Exposure  Quantity RR (95% CI) Adjustment for confounders 
Li et al, 2010, 
China 
Shanghai 
Women’s 
Health Study 
1997-2000 
– 2007, 9.1 
years 
follow-up 
73061 women, 
age 40-70 years: 
475 CRC cases  
Validated 
FFQ, 71 
food items 
Glycemic index 
Glycemic load 
Carbohydrate 
225.9 vs. 159.7 units/d 
76.0 vs. 64.4 units/d 
302.3 vs. 242.2 g/d 
0.94 (0.71-1.24) 
1.09 (0.81-1.46) 
0.87 (0.66-1.15) 
Age, birth year, education, income, BMI, 
physical activity, FH – CRC, HRT, total 
energy intake 
George et al, 
2008, USA 
NIH-AARP 
Diet and Health 
Study 
1995-96 – 
2003,  
 
262642 men and 
183535 women, 
age 50-71 yrs: 
3031/1457 CRC 
cases 
Validated 
FFQ, 124 
items 
Glycemic index, w 
Glycemic index, m 
Glycemic load, w 
Glycemic load, m 
≥56.6 vs. ≤50.4 units/d 
≥57.0 vs. ≤51.3 units/d 
≥135.3 vs. ≤66.9 units/d  
≥164.4 vs. ≤83.0 units/d 
1.16 (0.98-1.37)  
1.16 (1.04-1.30)  
0.87 (0.64-1.18)  
0.88 (0.72-1.08)  
Age, race/ethnicity, education, marital 
status, BMI, FH – any cancer, physical 
activity, smoking, alcohol, total energy 
intake 
Weijenberg et 
al, 2008, 
Netherlands 
Netherlands 
Cohort Study 
1986 – , 
11.3 years 
follow-up 
 
2072 men and 
2053 women, 
age 55-69 years: 
1225 CC cases 
418 RC cases 
Validated 
FFQ, 150 
items 
  
Glycemic index, m 
Glycemic index, w 
Glycemic load, m 
Glycemic load, w 
 
64.5 vs. 56.6 units/d 
61.9 vs. 53.7 units/d 
165.4 vs. 108.7 units/d 
123.6 vs. 82.5 units/d 
 
0.81 (0.61-1.08)  
1.20 (0.85-1.67) 
0.83 (0.64-1.08)  
1.00 (0.73-1.36) 
 
Age, BMI, FH – CC, smoking, total energy, 
calcium, alcohol, education, processed meat, 
physical activity 
Howarth et al, 
2008, USA 
Multiethnic 
Cohort Study 
1993-96 - 
2002, 8 yrs 
follow-up 
 
191004 men and 
women, age 45-
75 years: 2379 
CRC cases 
 
Validated 
FFQ, >180 
food items 
Glycemic load, m 
Glycemic load, w 
Carbohydrate, m 
Carbohydrate, w 
209 vs. 96 g/d 
171 vs. 82 g/d 
≥331.2 vs. <243.9 g/d 
≥281.1 vs. <234.5 g/d  
1.15 (0.89-1.48)  
0.75 (0.57-0.97)  
1.09 (0.84-1.40) 
0.71 (0.53-0.95)  
Age, ethnicity, time since cohort entry, CR 
polyp, pack-years of cigarette smoking, 
BMI, hours of vigorous activity, NSAID 
use, multivitamin use, hormone replacement 
use, energy intake, alcohol, red meat, folate, 
vitamin D, calcium, dietary fiber 
Kabat GC et 
al, 2008, USA 
Women’s 
Health Initiative 
1993-98 – , 
7.8 years 
follow-up 
 
158800 women, 
age 50-79 years: 
1476 CRC cases 
 
FFQ, 122 
food items 
Glycemic index 
Glycemic load  
Total carbohydrate 
Total sugars 
 
≥55.4 vs. <49.4 units/d 
≥126.6 vs. <62.4 units/d 
≥260.1 vs. <131.6 g/d 
≥129.7 vs. <58.8 g/d 
 
1.10 (0.92-1.32) 
1.11 (0.82-1.49) 
0.89 (0.64-1.25) 
1.16 (0.91-1.49) 
Age, education, cigarettes per day, BMI, 
height, HRT, diabetes mellitus, FH – CRC 
in 1
st
 degree relative, physical activity, 
observational study participant, total fiber, 
energy, dietary calcium 
Strayer L et la, 
2007, USA 
Breast Cancer 
Detection 
Demonstration 
Project 
1979-81 – 
1998, 8.5 
yrs follow-
up 
45561 women, 
mean age 61.9 
years: 490 CRC 
cases 
Validated 
FFQ, 62 
food items 
Carbohydrate 
Glycemic index 
Glycemic load 
>162 vs. <114 g/d 
>52.5 vs. <45 units/d 
>79.5 vs. <55.3 
0.70 (0.50-0.97)  
0.75 (0.56-1.00)  
0.91 (0.70-1.20) 
Age, dietary calories, NSAIDs use, fiber, 
smoking, menopausal hormone use, 
screened for colorectal cancer, BMI  
McCarl M et 
al, 2006, USA 
Iowa Women’s 
Health Study 
1986-2000, 
15 years 
follow-up 
35197 women, 
age 55-69 years: 
957 CRC cases 
FFQ, 127 
food items 
Glycemic index 
Glycemic load 
>89.3 vs. <81.0 units/d 
>193 vs. ≤146  
 
1.08 (0.88-1.32)  
1.09 (0.88-1.35) 
Age, energy intake, activity level, 
multivitamin use, diabetes, smoking, WHR 
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Larsson SC et 
al, 2006, 
Sweden 
Swedish 
Mammography 
Cohort 
1987-90 – 
2005, 15.7 
years 
follow-up 
61433 women, 
age 40-76 years: 
870 CRC cases 
 
Validated 
FFQ, 67 
food items 
Glycemic index 
Glycemic load 
Carbohydrate 
 
≥83.4 vs. <75.8 
≥200 vs. <164 units/d 
≥246 vs. <211 g/d 
 
1.00 (0.75-1.33) 
1.06 (0.81-1.39) 
1.10 (0.85-1.44) 
 
Age, education, BMI, total energy intake, 
alcohol, cereal fiber, folate, calcium, 
magnesium, red meat 
Michaud DS 
et al, 2005, 
USA 
Health 
Professionals 
Follow-up 
Study 
1986-2000, 
14 years 
follow-up 
 
47422 men, age 
45-75 years: 
696 CRC cases 
 
Validated 
FFQ, 131 
food items 
Glycemic index 
Glycemic load 
Carbohydrate 
Sucrose 
Fructose 
82 vs. 69 units/d 
223 vs. 131 units/d 
288 vs. 182 g/d 
67 vs. 26 g/d 
72 vs. 29 g/d 
1.14 (0.88-1.48) 
1.32 (0.98-1.79)  
1.27 (0.93-1.72)  
1.30 (0.99-1.69)  
1.37 (1.05-1.78)  
Age, FH – CC, prior endoscopy screening, 
aspirin use, height, BMI, pack-years of 
smoking before age 30 years, physical 
activity, cereal fiber, alcohol, calcium, 
folate, processed meat and beef, pork, lamb 
as main dish 
Michaud DS 
et al, 2005, 
USA 
Nurses’ Health 
Study 
1980-2000, 
20 years 
follow-up 
83927 women, 
age 34-59 years: 
1113 CRC cases 
 
 
Validated 
FFQ, 131 
food items 
Glycemic index 
Glycemic load 
Carbohydrate 
Sucrose 
Fructose 
81 vs. 65 units/d 
167 vs. 80 units/d 
202 vs. 110 g/d 
55 vs. 17 g/d 
68 vs. 22 g/d 
1.08 (0.87-1.34) 
0.89 (0.71-1.11)  
0.87 (0.68-1.11)  
0.89 (0.72-1.11)  
0.87 (0.71-1.07)  
Age, FH – CC, prior endoscopy screening, 
aspirin use, height, BMI, pack-years of 
smoking before age 30 years, physical 
activity, cereal fiber, alcohol, calcium, 
folate, processed meat and beef, pork, lamb 
as main dish 
Higginbotham 
S et al, 2004, 
USA 
Women’s 
Health Study 
1993-1996  
7.9 years 
follow-up 
 
38451 women, 
age ≥45 years: 
174 CRC cases 
 
Validated 
FFQ, 131 
food items 
Glycemic index 
Glycemic load 
Carbohydrate 
Sucrose 
Fructose  
57 vs. 49 units/d 
143 vs. 92 units/d 
267 vs. 177 g/d 
51 vs. 31 g/d 
56 vs. 31 g/d 
1.71 (0.98-2.98)  
2.85 (1.40-5.80)  
2.41 (1.10-5.27)  
1.51 (0.90-2.54)  
2.09 (1.13-3.87)  
Age, BMI, OC use, HRT, FH – CRC, 
smoking, alcohol use, physical activity, 
NSAID use, total energy intake, total fiber, 
total fat, folate, calcium, vitamin D 
Terry PD et al, 
2003, Canada 
Canadian 
National Breast 
Screening Study 
1980-1985 
– 2000, 
16.5 years 
follow-up 
49124 women, 
age 40-59 years: 
616 CRC cases 
Validated 
FFQ, 86 
food items 
Glycemic load 
Total carbohydrate 
Total sugar 
217 vs. 82.3 units/d 
≥249 vs. <143 g/d 
≥104 vs. <53 g/d 
1.05 (0.73-1.53) 
1.01 (0.68-1.51) 
1.03 (0.73-1.44) 
Age, energy intake, study center, treatment 
allocation, BMI, cigarette smoking, 
educational level, physical activity, OC use, 
HRT, parity, alcohol, red meat, folic acid 
Kato et al, 
1997, USA
  
New York 
University 
Women’s 
Cohort Study 
1985-1991 
– 1994, 7.1 
years 
follow-up 
14727 women, 
age 34-65 years: 
100 CRC cases 
 
FFQ, 70 
food items 
Carbohydrate Quartile 4 vs. 1 
 
1.21 (0.67-2.17) Age, total calories, place at enrollment, 
highest level of education 
Chyou PH et 
al, 1996, USA 
Honolulu Heart 
Program 
1965- 
1995, 22 
years 
follow-up 
 
7940 Japanese-
American men, 
age ≥45 years: 
330 CC cases 
123 RC cases 
24-hour 
dietary 
recall, 54 
food items 
Carbohydrate, CC 
Carbohydrate, RC 
≥54 vs. <40 % of energy 
≥54 vs. <40 % of energy 
 
1.04 (0.78-1.39) 
0.43 (0.24-0.75) 
Age  
Bostick, 1994, 
USA 
Iowa Women’s 
Health Study 
1986-1990, 
4.8 years 
follow-up 
35212 women, 
age 55-69 years: 
212 CC cases 
Validated 
FFQ, 127 
food items 
Total carbohydrate 
Sucrose 
Fructose 
 
>274 vs. 152 g/d  
62.5 vs. 25.8 g/d 
30.6 vs. 13.4 g/d 
 
1.30 (0.83-2.06) 
1.45 (0.88-2.39) 
0.93 (0.61-1.42) 
 
Age, total egergy, height, parity, total 
vitamin E, vitamin A supplement 
20 
 
BMI=Body Mass Index, CC=colon cancer, CR=colorectal, CRC=colorectal cancer, FFQ=food frequency questionnaire, FH=Family history, HPFS=Health Professionals 
Follow-up Study, HRT/HT=hormone therapy, m=men, MET=metabolic equivalent task, NHS=Nurses’ Health Study, RC=rectal cancer, w=women.  
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Table 2: Subgroup analyses of glycemic index, glycemic load, total carbohydrate and colorectal cancer, dose-response analysis 
 Glycemic index Glycemic load Total carbohydrate 
 n RR (95% CI) I
2
 (%) Ph
1 
Ph
2
 n RR (95% CI)  I
2
 (%) Ph
1 
Ph
2
 n RR (95% CI)  I
2
 (%) Ph
1 
Ph
2
 
All studies 10 1.07 (0.99-1.15) 39.0 0.10  12 1.00 (0.94-1.06) 49.9 0.03  9 0.97 (0.87-1.09) 51.2 0.04  
Duration of follow-up                
    <10 yrs follow-up 5 1.08 (0.92-1.27) 65.7 0.02 0.69 6 0.99 (0.90-1.09) 54.3 0.05 0.77 4 0.99 (0.80-1.23) 59.8 0.06 0.90 
    ≥10 yrs follow-up 5 1.06 (0.98-1.14) 0 0.73 6 1.01 (0.92-1.10) 50.6 0.07 5 0.97 (0.83-1.12) 52.7 0.08 
Sex                 
    Men  4 1.14 (1.04-1.24) 0 0.72 0.44 4 1.00 (0.88-1.13) 66.4 0.03 0.74 2 1.15 (0.98-1.35) 4.9 0.31 0.07 
    Women 8 1.05 (0.95-1.17) 48.9 0.06 11 0.98 (0.93-1.04) 24.9 0.21 8 0.92 (0.82-1.03) 40.1 0.11 
Subsite                 
    Colon  7 1.04 (0.95-1.13) 25.7 0.23 0.61 9 0.98 (0.91-1.05) 32.0 0.16 0.08 8 0.95 (0.86-1.06) 19.3 0.28 0.41 
    Rectum  7 1.09 (0.94-1.25) 0 0.92 9 1.11 (1.00-1.23) 0 0.74 7 1.03 (0.87-1.23) 0 0.59 
    Proximal colon 5 1.09 (0.97-1.22) 0 0.87 0.08 6 0.88 (0.78-1.00) 32.8 0.19 0.19 5 0.77 (0.60-0.98) 47.3 0.11 0.10 
    Distal colon 5 0.90 (0.78-1.04) 0 0.61 6 1.01 (0.88-1.16) 26.6 0.24 5 1.17 (0.87-1.59) 50.1 0.09 
Geographic location                 
    Europe 2 0.95 (0.80-1.14) 0 0.96 0.53 2 0.95 (0.82-1.10) 0 0.64 0.89 1 1.21 (0.74-1.98)   0.33 
    America 7 1.09 (1.00-1.20) 49.0 0.07 9 1.01 (0.94-1.10) 62.5 0.006 7 0.98 (0.87-1.10) 58.4 0.03 
22 
 
    Asia 1 1.02 (0.81-1.29)   1 0.94 (0.77-1.15)   1 0.76 (0.49-1.16)   
Number of cases                
    Cases <500 3 1.03 (0.76-1.38) 67.3 0.05 0.10 3 1.11 (0.75-1.62) 75.2 0.02 0.49 2 1.39 (0.38-5.06) 86.4 0.007 0.87 
    Cases 500-<1500 5 1.08 (1.00-1.16) 0 0.82 6 1.03 (0.95-1.12) 47.8 0.09 1 0.95 (0.82-1.12)   
    Cases ≥1500 2 1.10 (0.90-1.35) 60.4 0.11 3 0.95 (0.90-1.00) 0 0.64 6 0.97 (0.86-1.08) 44.1 0.11 
 
Alcohol  Yes  6 1.10 (1.00-1.20) 33.6 0.18 0.47 8 1.00 (0.92-1.08) 61.5 0.01 0.72 6 1.05 (0.87-1.25) 59.8 0.03 0.41 
No  4 1.02 (0.89-1.18) 48.2 0.12 4 1.03 (0.94-1.12) 0 0.46 3 0.91 (0.83-1.00) 4.4 0.35 
Smoking  
 
Yes  8 1.08 (0.99-1.18) 46.4 0.07 0.41 10 1.01 (0.94-1.08) 58.7 0.01 0.75 7 0.98 (0.87-1.10) 58.4 0.03 0.87 
No  2 0.98 (0.83-1.17) 0 0.68 2 0.96 (0.82-1.12) 0 0.76 2 0.94 (0.59-1.49) 49.0 0.16 
Body mass index, 
weight, WHR 
Yes  10 1.07 (0.99-1.15) 39.0 0.10 NA 12 1.00 (0.94-1.06) 49.9 0.03 NA 9 0.97 (0.87-1.09) 51.2 0.04 NA 
No  0    0    0    
Physical activity  
 
Yes  8 1.12 (1.06-1.18) 0 0.49 0.03 10 1.01 (0.94-1.08) 57.8 0.01 0.63 8 0.96 (0.86-1.08) 54.6 0.03 0.53 
No  2 0.88 (0.74-1.03) 0 0.39 2 0.94 (0.78-1.14) 0 0.50 1 1.21 (0.74-1.98)    
Red, processed meat Yes  4 1.04 (0.95-1.14) 0 0.70 0.48 6 0.99 (0.92-1.08) 45.0 0.11 0.92 5 0.99 (0.86-1.14) 39.3 0.16 0.68 
No  6 1.09 (0.96-1.23) 57.2 0.04 6 1.01 (0.91-1.13) 60.4 0.03 4 0.96 (0.77-1.18) 66.2 0.03 
Calcium intake Yes 6 1.06 (0.98-1.15) 0 0.48 0.98 7 1.04 (0.93-1.15) 63.2 0.01 0.40 6 1.05 (0.89-1.23) 58.2 0.04 0.19 
No 4 1.05 (0.90-1.22) 68.9 0.02 5 0.95 (0.91-1.00) 0 0.53 3 0.88 (0.80-0.97) 0 0.74 
23 
 
Fruits, vegetables Yes 0    NA 0    NA 0    NA 
No 10 1.07 (0.99-1.15) 39.0 0.10 12 1.00 (0.94-1.06) 49.9 0.03 9 0.97 (0.87-1.09) 51.2 0.04 
Folate  Yes 6 1.06 (0.95-1.18) 54.4 0.05 0.91 6 1.04 (0.92-1.17) 67.4 0.009 0.55 6 1.05 (0.87-1.25) 59.8 0.03 0.41 
No 4 1.07 (0.96-1.19) 14.6 0.32 6 0.97 (0.92-1.02) 6.7 0.37 3 0.91 (0.83-1.00) 4.4 0.35 
Energy intake Yes  10 1.07 (0.99-1.15) 39.0 0.10 NA 12 1.00 (0.94-1.06) 49.9 0.03 NA 9 0.97 (0.87-1.09) 51.2 0.04 NA 
No  0    0    0    
n denotes the number of studies, the number of risk estimates used is lower in some analyses as one publication reported a combined estimate for two 
studies (ref. no 13). 
1
 P for heterogeneity within each subgroup, 
2
 P for heterogeneity between subgroups with meta-regression analysis, 
3,4
 subgroup 
analyses restricted to studies that reported results both for men and women, 
5,6
 subgroup analyses restricted to studies that reported results both for 
colon and rectum. NA: not applicable because no studies were present in one of the subgroups.  
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Figure 1. Flow-chart of study selection 
 
 
 
 
 
 
 
58656 hits yielded from multiple electronic 
bibliographic databases and hand-searching 
43191 hits from WCRF 2
nd
 Expert Report 
(≤2005) 
15465 hits from the Continuous Update (Jan 
2006- December 2010) 
4073 full-text articles retrieved and assessed for 
inclusion 
1192 publications included in the WCRF systematic 
literature review 
18 publications from prospective studies reporting 
on the association between dietary carbohydrate, 
glycemic incex or glycemic load and colorectal 
cancer risk 
 
  
 
11 publications (11 studies) included in the dose 
response meta-analysis 
54583 excluded on the basis of title and abstract 
2881 articles excluded for not fulfilling the 
inclusion criteria 
1498 did not contain original data/reviews 
861 did not report on the associations of 
interest 
322 non peer-reviewed articles/commentary 
192 meta-analyses/pooled/ecological/cross-
sectional/migrant studies/ case reports 
8 articles with duplicate data 
4 publications excluded  
        4 publications did not provide risk estimates 
1175 publications excluded for reporting on 
exposures other than dietary carbohydrate, glycemic 
index or glycemic load or study design other than 
prospective study 
14 publications (14 studies) included in the high 
versus low meta-analysis 
3 publications excluded from the dose-response 
meta-analyses  
       2 carbohydrate  
          reported as percentage of energy intake 
       1 no quantities were reported 
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Figure 2. Glycemic index and colorectal cancer 
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 Overall   1.07 ( 0.99, 1.16)
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 Larsson, 2007   0.95 ( 0.74, 1.21)
 Strayer, 2007   0.82 ( 0.66, 1.02)
 McCarl, 2006   1.12 ( 0.95, 1.32)
 Michaud, 2005, HPFS   1.10 ( 0.91, 1.33)
 Michaud, 2005, NHS   1.06 ( 0.94, 1.20)
 Higginbotham, 2004   1.63 ( 0.97, 2.74)
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Figure 3. Glycemic load and colorectal cancer 
  Relative Risk
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 Relative Risk
 (95% CI)
 Li, 2010   0.94 ( 0.77, 1.15)
 George, 2009   0.94 ( 0.88, 1.00)
 Howarth, 2008   1.00 ( 0.89, 1.12)
 Kabat, 2008   1.07 ( 0.92, 1.24)
 Weijenberg, 2008   0.92 ( 0.77, 1.11)
 Larsson, 2007   0.99 ( 0.77, 1.27)
 Strayer, 2007   0.87 ( 0.64, 1.17)
 McCarl, 2006   1.08 ( 0.93, 1.26)
 Michaud, 2005, NHS   0.92 ( 0.82, 1.03)
 Michaud, 2005, HPFS   1.20 ( 1.04, 1.39)
 Higginbotham, 2004   2.29 ( 1.24, 4.23)
 Terry, 2003   0.96 ( 0.84, 1.11)
 Overall   1.00 ( 0.94, 1.06)
  Relative Risk
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 Study
 Relative Risk
 (95% CI)
 Li, 2010   0.94 ( 0.71, 1.24)
 George, 2009   0.88 ( 0.74, 1.04)
 Howarth, 2008   0.94 ( 0.78, 1.13)
 Kabat, 2008   1.11 ( 0.82, 1.49)
 Weijenberg, 2008   0.90 ( 0.73, 1.10)
 Larsson, 2007   1.06 ( 0.81, 1.39)
 Strayer, 2007   0.91 ( 0.70, 1.20)
 McCarl, 2006   1.09 ( 0.88, 1.35)
 Michaud, 2005, HPFS   1.32 ( 0.98, 1.79)
 Michaud, 2005, NHS   0.89 ( 0.71, 1.11)
 Higginbotham, 2004   2.85 ( 1.40, 5.80)
 Terry, 2003   1.05 ( 0.73, 1.53)
 Overall   1.00 ( 0.91, 1.10)
B Glycemic load, dose-response per 50 units/day
Glycemic load, high vs. low intakeA
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Figure 4. Total carbohydrate and colorectal cancer 
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 Relative Risk
 (95% CI)
 Li, 2010   0.87 ( 0.66, 1.15)
 Howarth, 2008   1.09 ( 0.84, 1.40)
 Kabat, 2008   0.89 ( 0.64, 1.25)
 Larsson, 2007   1.10 ( 0.85, 1.44)
 McCarl, 2006   0.79 ( 0.65, 0.97)
 Michaud, 2005, HPFS   1.27 ( 0.93, 1.72)
 Michaud, 2005, NHS   0.87 ( 0.68, 1.11)
 Higginbotham, 2004   2.41 ( 1.10, 5.27)
 Terry, 2003   1.01 ( 0.68, 1.51)
 Kato, 1997   1.21 ( 0.67, 2.17)
 Overall   1.00 ( 0.87, 1.14)
Total carbohydrates, high vs. low intakeA
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 Relative Risk
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 Li, 2010   0.76 ( 0.49, 1.16)
 Howarth, 2008   0.95 ( 0.82, 1.12)
 Kabat, 2008   0.99 ( 0.84, 1.16)
 Larsson, 2007   1.21 ( 0.74, 1.98)
 McCarl, 2006   0.88 ( 0.79, 0.98)
 Michaud, 2005, HPFS   1.28 ( 0.99, 1.65)
 Michaud, 2005, NHS   0.86 ( 0.68, 1.08)
 Higginbotham, 2004   2.84 ( 1.21, 6.67)
 Terry, 2003   0.92 ( 0.72, 1.17)
 Overall   0.97 ( 0.87, 1.09)
Total carbohydrates, dose-response per 100 g/dB
 
 
 
 
 
29 
 
Figure 5. Fructose and sucrose intake and colorectal cancer, high versus low analysis 
A
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Additional material: 
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Glycemic index 
 
 
 
.8
1
1
.2
1
.4
1
.6
1
.8
2
E
s
ti
m
a
te
d
 R
R
0 10 20 30 40 50 60 70 80 90 100
Glycemic index (g/day)
Best fitting fractional polynomial
95% confidence interval
.5
1
1
.5
2
E
s
ti
m
a
te
d
 R
R
40 50 60 70 80 90
Glycemic index (g/day)
Reference categories
RR for glycemic index
32 
 
 
Glycemic load  
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